原文传递: https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.31884 肝硬化 无细胞浓缩腹水回输疗法(CART)可以显著改善肝硬化腹水患者白蛋白水平 Journal of gastroenterology and hepatology IF:4.029 腹水是失代偿期肝硬...
8.Murata K, et al. Immunomodulatory mechanism of acyclic nucleoside phosphates in treatment of hepatitis B virus infection. Hepatology. 2019 Sep 17. doi: 10.1002/hep.30956 部分图片来源网络 转载自国际肝病网,版权归原作者
4.Terrault NA, Lok AS, McMahon BJ, et al. Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology. 2018, <https://doi.org/10.1002/hep.29800> 备注说明:...
doi:10.1002/hep.28156Norah A TerraultNatalie H BzowejKyong-Mi ChangJessica P HwangM Hassan MuradJohn Wiley & Sons, Ltd.HepatologyTERRAULT NA, BZOWEJ NH, CHANG KM, et al. AASLD guidelines for treatment of chronic hepatitis B[ J ]. Hepatolo- gy, 2016, 63(1}; 261 -283....
All persons with chronic kidney disease await-ing renal replacement therapy, namely hemodialysisor kidney transplantation, should be screened for hep-atitis C in order to plan for management and treat-ment (Class I, Level B).38. The decision to perform a liver biopsy in pa-tients with ...
(b)AmericanCol-legeofPhysiciansManualforAssessingHealthPracticesandDesigningPracticeGuidelines.1(c)guidelinepoli-cies,includingtheAASLDPolicyontheDevelopmentandUseofPracticeGuidelinesandtheAGAPolicyState-mentonGuidelines2;(d)theexperienceoftheauthorsinthespecifiedtopic.Wehavealsoreviewedtheguidelinespreparedatthe...
5.Mina S. Farag, Scott K. Fung, Dr. Edward Tam, et al. Tenofovir Alafenamide Fumarate Is Effective and Has Superior Renal Safety Mainly among Stage 2 Chronic Kidney Disease (CKD): Real-world Study from the Canadian Hepatitis B Network (CANHEPB). AASLD 2019 Abstract Number: 0481. ...
5.Mina S. Farag, Scott K. Fung, Dr. Edward Tam, et al. Tenofovir Alafenamide Fumarate Is Effective and Has Superior Renal Safety Mainly among Stage 2 Chronic Kidney Disease (CKD): Real-world Study from the Canadian Hepatitis B Network (CANHEPB). AASLD 2019 Abstract Number: 0481. ...
2.Terrault NA, Lok AS, McMahon BJ, et al. Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology. 2018, https://doi.org/10.1002/hep.29800 3.Chan HL, Lim YS, Seto WK, et al. Three Year Efficacy and Safety of Tenofovir...
4.TerraultNA,LokAS,McMahonBJ,etal.UpdateonPrevention,Diagnosis,andTreatmentandofChronicHepatitisB:AASLD2018HepatitisBGuidance.Hepatology.2018,https://doi.org/10.1002/hep.29800 5.JeongJY,JunDW,SohnJH,etal.RenalSafetyofEntecavirandTenofovirinPatientswithTreatment-Nai?NveChronicHepatitisBVirusInfectioninRealLife...